

Cover Story
Free
By Matthew Bin Han Ong
Anil Potti, in a Duke commercial advertising the trial Shoffner joined.Joyce Shoffner would never have predicted that Duke University, an institution she revered and at one time worked for, would put her in a breast cancer clinical trial testing a fraudulent technology.
In Brief
Drugs & Targets
Trending Stories
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Fired NCI employee says Trump’s purge was baseless yet punitive
“I feel like I’ve been erased” - Former CDER Director Patrizia Cavazzoni named Pfizer chief medical officer, executive vice president
- Biden’s FY23 proposal cuts NCI funds by $199M, while boosting ARPA-H by $4B
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Biomarker-driven innovation: What the FDA’s evolving strategy means for oncology